Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Predictors of vascular access site complications during angioplasty with eptifibatide

July 31, 1998

Ibex suspends phase III trial of Neutralase pending further analysis of data

July 30, 1998

BTG offers novel iron complexes for licensing

July 30, 1998

Reduced incidence of death following hirudin/streptokinase therapy for acute myocardial infarction

July 30, 1998

Rights to rhFIX gene for use in gene therapy available from BTG

July 29, 1998

Platelet activity after coronary thrombolysis with reteplase and alteplase

July 29, 1998

Antiplatelet agents in the pipeline at Boehringer Ingelheim

July 28, 1998

Wakunaga researchers patent new antiplatelet agents

July 17, 1998

New antiischemic agent put on the developmental track at Otsuka

July 17, 1998

Clopidogrel approved throughout European Union

July 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.